PARIS COFIELD: Open Payments
NPI 1194382184 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,861 in 79 payments from 11 companies in 2025. Trend: 2023 $2,057 · 2024 $1,877 · 2025 $1,861
Food & beverage: $1,861
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $396 |
| ABBVIE INC. | 14 | $359 |
| Celltrion USA Inc. | 11 | $303 |
| Ardelyx, Inc. | 9 | $193 |
| Janssen Biotech, Inc. | 9 | $167 |
| PFIZER INC. | 6 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Lilly USA, LLC | 5 | $95 |
| Medtronic, Inc. | 1 | $66 |
| Organon LLC | 1 | $20 |
Products named: ENTYVIO, VEGZELMA, SKYRIZI, IBSRELA, TREMFYA, RINVOQ, DUPIXENT, ZYMFENTRA.
Industry payments across VA — which companies pay providers there.
